Picks for 1/10/2022

SDPI - Price has been consolidating for about a month and the MACD recently crossed. We also see a double bottom in December. With the price closing above the .23 fib level and the DI+ crossing the DI-on the ADX in recent days It looks like a bullish reversal is in coming.


Targeting: .9055, .9819, 1. 05in the short term.

RVPH - Food and Drug Administration (FDA) has notified the Company that it may proceed with Phase 3 clinical investigation of its lead candidate, brilaroxazine, a novel serotonin and dopamine receptor modulator for the treatment of schizophrenia.


Also watching: T, NLST, HALL, LTRX, IEP

8 views0 comments

Recent Posts

See All

TG - Originally picked this on 2/17 and after hitting my target it has retraced and appears to be setting up again with a recent MACD cross and close above the .5 fib level are very bullish . Also h

EXTN - Hit my prior target ($7.36) in 15 trading days. I remain bullish and up the target to $8.09 Also watching: AUY, BKR, ARKO, FTI, TG

ELMD - We see a series of higher lows since November 2020 and a recent break out above the descending trend line on the weekly chart ( wedge ). Also the MACD is crossing over and momentum recently c